Marius Pop
Affiliations: | 2014-2016 | Biological Engineering | Massachusetts Institute of Technology, Cambridge, MA, United States |
Google:
"Marius Pop"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Freeman DB, Hopkins TD, Mikochik PJ, et al. (2023) Discovery of KB-0742, a Potent, Selective, Orally Bioavailable Small Molecule Inhibitor of CDK9 for MYC-Dependent Cancers. Journal of Medicinal Chemistry |
Richters A, Doyle SK, Freeman DB, et al. (2020) Modulating Androgen Receptor-Driven Transcription in Prostate Cancer with Selective CDK9 Inhibitors. Cell Chemical Biology |
Akande OE, Damle PK, Pop M, et al. (2019) DBC1 Regulates p53 Stability via Inhibition of CBP-Dependent p53 Polyubiquitination. Cell Reports. 26: 3323-3335.e4 |
Struntz NB, Chen A, Deutzmann A, et al. (2019) Stabilization of the Max Homodimer with a Small Molecule Attenuates Myc-Driven Transcription. Cell Chemical Biology |
Sandoval GJ, Pulice JL, Pakula H, et al. (2018) Binding of TMPRSS2-ERG to BAF Chromatin Remodeling Complexes Mediates Prostate Oncogenesis. Molecular Cell |
Boskovic ZV, Kemp MM, Freedy AM, et al. (2016) Inhibition of zinc-dependent histone deacetylases with a chemically triggered electrophile. Acs Chemical Biology |
Doyle SK, Pop MS, Evans HL, et al. (2015) Advances in discovering small molecules to probe protein function in a systems context. Current Opinion in Chemical Biology. 30: 28-36 |
Pop MS, Wassaf D, Koehler AN. (2014) Probing small-molecule microarrays with tagged proteins in cell lysates. Current Protocols in Chemical Biology. 6: 209-20 |
Theurillat JP, Udeshi ND, Errington WJ, et al. (2014) Prostate cancer. Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer. Science (New York, N.Y.). 346: 85-89 |
Pop MS, Stransky N, Garvie CW, et al. (2014) A small molecule that binds and inhibits the ETV1 transcription factor oncoprotein. Molecular Cancer Therapeutics. 13: 1492-502 |